Yubo International Biotech Limited
YBGJ
$0.0428
$0.00287.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.78M | -2.00M | -1.42M | -1.26M | -1.20M |
| Total Depreciation and Amortization | 183.30K | 256.00K | 254.70K | 227.00K | 190.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.50K | 73.00K | -272.60K | -32.20K | 0.00 |
| Change in Net Operating Assets | 248.90K | 710.80K | 568.20K | 234.30K | 266.10K |
| Cash from Operations | -1.34M | -963.40K | -865.70K | -826.70K | -739.00K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | -18.90K | -- |
| Sale of Property, Plant, and Equipment | 118.50K | 118.50K | 82.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | -11.10K | -- |
| Cash from Investing | 118.50K | 118.50K | 82.00K | -30.00K | -- |
| Total Debt Issued | 1.03M | 745.70K | 745.70K | 745.70K | 745.70K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 374.60K | 297.80K | 272.40K | 98.00K | -- |
| Cash from Financing | 1.41M | 1.04M | 1.02M | 843.70K | 745.70K |
| Foreign Exchange rate Adjustments | -187.20K | -195.70K | -231.80K | 39.90K | -18.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 700.00 | 2.80K | 2.60K | 26.90K | -11.80K |